LumiraDx Gets FDA Emergency Use Authorization Amendment For Its LumiraDx SARS-CoV-2 RNA Star Complete Test Kit To Extend The Shelf Life To 12 Months
https://www.fda.gov/media/165719/download
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Walt Disney And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
Raymond James Maintains Outperform on LumiraDx, Lowers Price Target to $3.5
Raymond James analyst Andrew Cooper maintains LumiraDx (NASDAQ:LMDX) with a Outperform and lowers the price target from $4 to $3.5.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers
Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX dose groups.
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au